IO Biotech regains Nasdaq minimum bid price compliance after deficiency notice

IO Biotech, Inc.

Received December 26, 2024 notice from Nasdaq for bid price below $1.00 for 30 consecutive days.
On June 3, 2025, Nasdaq Staff confirmed closing bid price at $1.00+ for 10 consecutive business days.
Company has regained compliance with Nasdaq Listing Rule 5450(a)(1); matter is closed.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.